2009

1. Flow Cytometry Remission Is the Most Relevant Prognostic Factor for MM Patients Who Undergo ASCT

   CLINICAL LYMPHOMA & MYELOMA

2. The Presence of Normal PC at Diagnosis by Flow Cytometry is a Favorable Prognostic Feature in MM

   CLINICAL LYMPHOMA & MYELOMA